Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease

Volume: 2016, Issue: 5
Published: Oct 30, 2015
Abstract
The therapeutic role of 6-mercaptopurine (6-MP) and azathioprine (AZA) remains controversial due to their perceived relatively slow-acting effect and adverse effects. An updated meta-analysis was performed to evaluate the efficacy of these agents for the maintenance of remission in quiescent Crohn's disease.To assess the efficacy of AZA and 6-MP for maintenance of remission in quiescent Crohn's disease.We searched MEDLINE, EMBASE, and the...
Paper Details
Title
Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease
Published Date
Oct 30, 2015
Volume
2016
Issue
5
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.